Log in

News

  • Home
  • Resources
  • Literature Updates
  • Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

30 Aug 2018 6:06 AM | ISDE Office (Administrator)

Yang H.; Liu H.; Chen Y.; Zhu C.; Fang W.; Yu Z.; Mao W.; Xiang J.; Han Y.; Chen Z.; Yang H.; Wang J.; Pang Q.; Zheng X.; Yang H.; Li T.; Lordick F.; D'Journo X.B.; Cerfolio R.J.; Korst R.J.; Novoa N.M; Swanson S.J.; Brunelli A.; Ismail M.; Fernando HC.; Zhang X.; Li Q.; Wang G.; Chen B.; Mao T.; Kong M.; Guo X.; Lin T.; Liu M.; Fu J.

Click here to read full abstract.

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software